FineHeart Receives Slovenia JAZMP (Agency for Medicinal Products and Medical Devices of the Republic of Slovenia) Authorization to Launch Its FIH Clinical Study on Patients Suffering From Advanced Heart Failure
FineHeart S.A., a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announces that it has received authorization from JAZMP, the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia, to begin its First-In-Human (FIH) clinical study.
FineHeart Receives ANSM1 Authorization to Deploy Its First-In-Human Clinical Study in France
FineHeart S.A., a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announces that it has received authorization from the French National Agency for the Safety of Medicines and Health Products (ANSM) to initiate its First-In-Human (FIH) clinical trial in France.
